Monday, October 28, 2019

General Dental Devices And Equipment Market Global Opportunities And Strategies To 2022

General Dental Devices And Equipment Market


A recent report published by The Business Research Company on General Dental Devices And Equipment Market provides in-depth analysis of segments and sub-segments in the global as well as regional.

The global general dental devices and equipmentmarket was valued at about $8.3 billion in 2018 and is expected to grow to $10.32 billion at a CAGR of 5.6% through 2022.

The general dental equipment market consists of sales of general dental equipment and related services. General dental equipment and dental products are used in dental surgeries. Major products include dental implants, dental crowns, bridges, dental filling caps, orthodontic cases, dentures (false teeth), casting machines, instrument delivery systems etc.


Major players in the market are Straumann, 3M Company, Zimmer Biomet Holdings, Inc., Danaher Corporation , Denstply International Inc.

The changing lifestyles and unhealthy eating habits such as consumption of sugar-filled sodas, sweetened fruit drinks or non-nutritious snacks and smoking, inadequate oral hygiene have increased the prevalence of tooth problems. The demand for dental care is directly affecting dental devices or equipment companies. According to WHO, in 2016, 3.58 billion people were affected by periodontal (gum) diseases globally.

North America was the largest region in the general dental devices and equipment market in 2018. This region is expected to remain the largest during the next five years. The general dental devices and equipment market in Europe is forecasted to register the highest CAGR during 2018-2023.

Few Points From Table Of Content
1. Executive Summary
2. General Dental Devices And Equipment Market Characteristics
3. General Dental Devices And Equipment Market Size And Growth
4. General Dental Devices And Equipment Market Segmentation
5. General Dental Devices And Equipment Market Regional And Country Analysis
6. Asia-Pacific General Dental Devices And Equipment Market
7. China General Dental Devices And Equipment Market
8. India General Dental Devices And Equipment Market
9. Japan General Dental Devices And Equipment Market
10. Australia General Dental Devices And Equipment Market
11. Indonesia General Dental Devices And Equipment Market
12. South Korea General Dental Devices And Equipment Market


About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

ENT Surgical Devices And Equipment Market Size, Growth And Trends



A recent report published by The Business Research Company on ENT Surgical Devices And Equipment Market provides in-depth analysis of segments and sub-segments in the global as well as regional.

The global ENT surgical devices and equipment market was valued at about $1.3 billion in 2018 and is expected to grow to $1.48 billion at a CAGR of 3.3% through 2022.

The ENT surgical devices and equipment market consists of sales of ENT (ear-nose-throat) surgical devices. ENT surgical devices include balloon sinus dilation devices, powered surgical instruments, ENT supplies, radiofrequency devices, ear tubes and handheld instruments are used to perform surgical procedures such as tonsillectomy, tracheostomy, implantations, septorhinoplasty, turbinate reduction, mastoidectomy, stapedectomy and reconstruction surgeries.


Major players in the market are Carl Zeiss Meditec AG, Stryker, Shanghai Fosun Pharmaceuticals Ltd., KLS Martin LP, Acclarent, Inc.

Increasing demand and adoption of minimally invasive ENT surgeries will drive the ENT surgical devices and equipment market in the future. For example, minimally invasive ENT surgeries offers patients with many benefits such as smaller incisions, faster recovery times, reduced pain, and scarring. In majority of the cases physicians enjoy higher accuracy rate compared to traditional open surgery. These supreme benefits of minimally invasive ENT surgeries will drive the market.

The ENT surgical devices and equipment industry has lately witnessed a rise in number of FDA clearances which would positively impact the market growth. A pre-market approval by FDA through FDA 510(K) is required for all the medical devices including ENT surgical devices. As announced by FDA in November 2018, the FDA 510(K) is expected to see number of updates in order to regulate safety, technology, and capabilities in the medical devices space.


Few Points From Table Of Content
1. Executive Summary
2. ENT Surgical Devices And Equipment Market Characteristics
3. ENT Surgical Devices And Equipment Market Size And Growth
4. ENT Surgical Devices And Equipment Market Segmentation
5. ENT Surgical Devices And Equipment Market Regional And Country Analysis
6. Asia-Pacific ENT Surgical Devices And Equipment Market
7. China ENT Surgical Devices And Equipment Market
8. India ENT Surgical Devices And Equipment Market
9. Japan ENT Surgical Devices And Equipment Market
10. Australia ENT Surgical Devices And Equipment Market
11. Indonesia ENT Surgical Devices And Equipment Market
12. South Korea ENT Surgical Devices And Equipment Market


About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info








Cardiac Assist Devices And Equipment Market 2019-2022 Industry Size Share Report


The Business Research Company’s Cardiac Assist Devices And Equipment Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

The global cardiac assist devices and equipment market was valued at about $0.92 billion in 2018 and is expected to grow to $1.14 billion at a CAGR of 5.5% through 2022.

The cardiac assist devices and equipment market consists of sales of cardiac assist devices and equipment and related services. Cardiac assist devices and equipment are electromechanical devices for assisting cardiac circulation, which are used either to partially or to completely replace the function of a failing heart.


Rise in prevalence of cardiovascular diseases increase the demand for cardiac assist devices and equipment in developed and developing economies. The increasing need for diagnosis, monitoring, early stage treatment, and prevention of these life-threatening diseases, increase the demand for cardiac assist devices.

Device miniaturization is becoming popular in the cardiac assist devices and equipment market. The concept of minimizing the size of the cardiac assist devices enhances device implantation, provides potentially shorter hospital stay through the use of less invasive surgery such as 'Thoracotomy'. Cardiac assist device miniaturization acts as a replacement to heart transplantation as a destination therapy, due to lack of heart donors.


Table Of Content
1. Executive Summary
2. Cardiac Assist Devices and Equipment Market Characteristics
3. Cardiac Assist Devices and Equipment Market Size And Growth
4. Cardiac Assist Devices and Equipment Market Segmentation
5. Cardiac Assist Devices and Equipment Market Regional And Country Analysis
6. Asia-Pacific Cardiac Assist Devices and Equipment Market 
7. China Cardiac Assist Devices and Equipment Market 
8. India Cardiac Assist Devices and Equipment Market
9. Japan Cardiac Assist Devices and Equipment Market 
10. Australia Cardiac Assist Devices and Equipment Market
11. Indonesia Cardiac Assist Devices and Equipment Market
12. South Korea Cardiac Assist Devices and Equipment Market
.
.
.
25. Cardiac Assist Devices and Equipment Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Cardiac Assist Devices and Equipment Market
27. Cardiac Assist Devices and Equipment Market Trends And Strategies
28. Cardiac Assist Devices and Equipment Market Future Outlook and Potential Analysis
29. Appendix


About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Thursday, October 24, 2019

Therapeutic Proteins Market Size, Growth, Trends, Industry Forecast Report 2022



A recent report published by The Business Research Company on Therapeutic Proteins Market provides in-depth analysis of segments and sub-segments in the global as well as regional.

The global therapeutic proteins market was valued at about $93.14 billion in 2018 and is expected to grow to $172.87 billion at a CAGR of 16.7% through 2022.

The therapeutic proteins market consists of sales of therapeutic proteins. Therapeutic proteins provide important therapies for diseases such as diabetes, cancer, infectious diseases, hemophilia, and anemia.


Major players in the market are Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd

Advance technologies for protein-based drug development drives the therapeutic proteins market. Therapeutic proteins cannot be synthesized chemically, they need to be produced by genetic engineering and recombinant DNA technology in living cells or organisms. Protein-engineering platform technologies such as glycoengineering, pegylation, Fc-fusion, albumin fusion, albumin drug conjugation help to increase the production yield, product purity, circulating half-life, targeting, and functionality of therapeutic protein drugs. 

In the United States, therapeutic protein drug manufacturers file therapeutic biologics application (BLA) to FDA for the product approvals. The drug approved through BLA should be proved as safe, pure and potent. FDA consolidated review of most therapeutic proteins in Center for Drug Evaluation and Research (CDER). In European Union, biologics are regulated by Committee for Medicinal Products for Human Use (CHMP) for marketing authorization.’

Few Points From Table Of Content
1. Executive Summary
2. Therapeutic Proteins Market Characteristics
3. Therapeutic Proteins Market Size And Growth
4. Therapeutic Proteins Market Segmentation
5. Therapeutic Proteins Market Regional And Country Analysis
6. Asia-Pacific Therapeutic Proteins Market
7. China Therapeutic Proteins Market
8. India Therapeutic Proteins Market
9. Japan Therapeutic Proteins Market
10. Australia Therapeutic Proteins Market
11. Indonesia Therapeutic Proteins Market
12. South Korea Therapeutic Proteins Market


About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Monoclonal Antibodies Market Size, Growth, Trends & 2022 Forecast Report

Monoclonal Antibodies Market


A recent report published by The Business Research Company on Monoclonal Antibodies Market provides in-depth analysis of segments and sub-segments in the global as well as regional.

The global monoclonal antibodies (mabs) market was valued at about $135.38 billion in 2018 and is expected to grow to $212.64 billion at a CAGR of 12.0% through 2022.

The monoclonal antibodies (MABS) market consists of sales of monoclonal antibodies and related services. Monoclonal antibodies are used to enhance and suppress immune response in various medical conditions and to treat various diseases such as cancer, cardiovascular and cerebrovascular diseases.


Major players in the market are Johnson & Johnson, Merck, AbbVie, Amgen, Glaxosmithkline plc

Alternative treatment methods and natural remedies are increasingly becoming popular globally and this is expected to have a negative impact on the revenues of monoclonal antibody drugs market. Treatments in the fields of homeopathy, Ayurveda, yoga, acupuncture, sujok therapy are gaining popularity and slowly replacing some traditional hospital practices.

The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human Services, in the USA regulating the monoclonal antibodies and pharmaceutical drugs market. Increasing product launches and regulatory support for the treatment of rare diseases by USFDA is expected to support the monoclonal antibody therapeutics market growth.

Few Points From Table Of Content
1. Executive Summary
2. Monoclonal Antibodies Market Characteristics
3. Monoclonal Antibodies Market Size And Growth
4. Monoclonal Antibodies Market Segmentation
5. Monoclonal Antibodies Market Regional And Country Analysis
6. Asia-Pacific Monoclonal Antibodies Market
7. China Monoclonal Antibodies Market
8. India Monoclonal Antibodies Market
9. Japan Monoclonal Antibodies Market
10. Australia Monoclonal Antibodies Market
11. Indonesia Monoclonal Antibodies Market
12. South Korea Monoclonal Antibodies Market


About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Cardiac Rhythm Management Devices And Equipment Market Size, Growth, Trends & 2022 Forecast Report

Cardiac Rhythm Management Devices And Equipment Market


A recent report published by The Business Research Company on Cardiac Rhythm Management Devices And Equipment Market provides in-depth analysis of segments and sub-segments in the global as well as regional.

The global cardiac rhythm management (crm) devices and equipment market was valued at about $12.28 billion in 2018 and is expected to grow to $14.42 billion at a CAGR of 4.1% through 2022.

The cardiac rhythm management (CRM) devices and equipment market comprises of sales of devices that are effective in managing and restoring the heart’s normal function or rhythm. These devices are used to treat and manage arrhythmia-related diseases such as cardiac arrests, heart failure, or cardiac arrhythmias.


Major players in the market are Abbott, Medtronic , Biotronik, Cardiac Science Corporation, Schiller AG

North America was the largest region in the cardiac rhythm management devices and equipment market in 2017, accounting by 51.5% of the market, followed by Europe, which accounts for 28.3%.

The rising incidences of cardiovascular diseases such as cardiac arrhythmia, ischemic heart disease, and hypertension is driving the CRM devices market. Sedentary lifestyles and medical conditions such as high cholesterol, high blood pressure, obesity and diabetes are major causes of cardiovascular diseases. According to the World Health Organization, in 2016, an estimated 17.9 million people died due to cardiovascular diseases accounting for 31% of all global deaths.

Manufacturers of cardiac rhythm management devices and equipment are governed by various regulatory bodies such as the FDA in the USA. The United States Food and Drug Administration recalls any product with safety issues or defects and that can endanger the consumer.

Few Points From Table Of Content
1. Executive Summary
2. Cardiac Rhythm Management Devices And Equipment Market Characteristics
3. Cardiac Rhythm Management Devices And Equipment Market Size And Growth
4. Cardiac Rhythm Management Devices And Equipment Market Segmentation
5. Cardiac Rhythm Management Devices And Equipment Market Regional And Country Analysis
6. Asia-Pacific Cardiac Rhythm Management Devices And Equipment Market
7. China Cardiac Rhythm Management Devices And Equipment Market
8. India Cardiac Rhythm Management Devices And Equipment Market
9. Japan Cardiac Rhythm Management Devices And Equipment Market
10. Australia Cardiac Rhythm Management Devices And Equipment Market
11. Indonesia Cardiac Rhythm Management Devices And Equipment Market
12. South Korea Cardiac Rhythm Management Devices And Equipment Market


About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Wednesday, October 23, 2019

Protein Expression Market Size, Growth, Trends And Industry Analysis Report by TBRC

Protein Expression Market

A recent report published by The Business Research Company on Protein Expression Market provides in-depth analysis of segments and sub-segments in the global as well as regional.

The global protein expression market was valued at about $1.74 billion in 2018 and is expected to grow to $2.63 billion at a CAGR of 10.9% through 2022.

The protein expression market consists of sales of protein expression vectors, competent cells, reagents, equipment and related services. Protein expression is a process in which proteins are synthesized, modified, regulated and controlled in living organisms according to the host cell. Protein expression included yeast expression, insect expression, and bacterial expression, algal expression and mammalian cell expression.


Major players in the market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs and Promega Corporation.

Increase in demand for biologics to counter various genetic disorders and chronic diseases is one the major factors driving the research and sales of protein expression market. Biologics is a medicine produced from living organisms or contains components of living organisms such as protein, tissue, genes, allergens, cells, blood components, blood, and vaccines. The increasing use of biologics (therapeutic protein and others) to cure chronic diseases such as cancer, cardiovascular conditions and genetic disorders, is increasing the demand for protein expression devices and equipment. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020.

North America was the largest region in the protein expression market in 2018. The protein expression market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

Few Points From Table Of Content
1. Executive Summary
2. Protein Expression Market Characteristics
3. Protein Expression Market Size And Growth
4. Protein Expression Market Segmentation
5. Protein Expression Market Regional And Country Analysis
6. Asia-Pacific Protein Expression Market
7. China Protein Expression Market
8. India Protein Expression Market
9. Japan Protein Expression Market
10. Australia Protein Expression Market
11. Indonesia Protein Expression Market
12. South Korea Protein Expression Market


About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company      

Pain Management Devices And Therapies Market Size, Growth, Trends, Industry Forecast Report 2022

Pain Management Devices And Therapies Market

A recent report published by The Business Research Company on Pain Management Devices And Therapies Market provides in-depth analysis of segments and sub-segments in the global as well as regional.

The global pain management devices and therapiesmarket was valued at about $4.17 billion in 2018 and is expected to grow to $5.68 billion at a CAGR of 8.1% through 2022.

The pain management devices and therapies market consists of sales of pain management devices and therapies to manage chronic and critical pain in patients suffering from various conditions, such as cancer and neurological disorder. This market includes the sales of light based devices, TENS (transcutaneous electrical nerve stimulation) for home, and other devices mainly used for Spinal cord stimulation, sacral nerve stimulators and deep brain stimulation.


Major players in the market are Abbott Laboratories, AstraZeneca, Pfizer, Boston Scientific Corporation and GlaxoSmithKline PLC.

Increase in demand for pain management devices due rise in chronic diseases is driving the growth of pain management devices and therapies market. Chronic diseases such as cancer, heart stroke, etc often leads to unbearable pain in patients and thus creating a demand for pain management drugs and therapies. Chronic diseases persists over a long period of time and deteriorates the health of the patient. 

Availability of other alternatives to manage pain is restraining the growth of the pain management devices and therapies market. Alternatives treatment methods such as acupuncture, Marijuana treatment, dietary supplements, and vitamins, etc. are being used instead of expensive pain relief devices and equipment. These alternative treatments may help with pain from bad backs, osteoarthritis, and headaches.

Few Points From Table Of Content
1. Executive Summary
2. Pain Management Devices And Therapies Market Characteristics
3. Pain Management Devices And Therapies Market Size And Growth
4. Pain Management Devices And Therapies Market Segmentation
5. Pain Management Devices And Therapies Market Regional And Country Analysis
6. Asia-Pacific Pain Management Devices And Therapies Market
7. China Pain Management Devices And Therapies Market
8. India Pain Management Devices And Therapies Market
9. Japan Pain Management Devices And Therapies Market
10. Australia Pain Management Devices And Therapies Market
11. Indonesia Pain Management Devices And Therapies Market
12. South Korea Pain Management Devices And Therapies Market


About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info


Natural Skin Care Products Market Key Opportunities And Strategies 2023-2032

The Natural Skin Care Products Global Market Report 2023, provides comprehensive information on the natural skin care products market across...